NEW YORK (GenomeWeb) – UK health policy think tank PHG Foundation has released a report detailing recommendations on developing effective testing services for circulating tumor DNA in lung cancer patients.

The report was informed by a workshop the foundation held in March 2017 — which included input from clinicians, UK National Health Service clinical scientists, and representatives from the life science and biotech industry — to identify and focus on the most pressing issues affecting the implementation of effective and equitable ctDNA testing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.